Ksenia V. Kastanenka

CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer’s Disease

Bence György, Camilla Lööv, Mikołaj Piotr Zaborowski et al. · Molecular Therapy — Nucleic Acids · 2018 · 189 citations · Full text

Life Sciences, Genetics, Neuroscience +17

Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study

Julien Dumurgier, Susanna Schraen, Audrey Gabelle et al. · Alzheimer s Research & Therapy · 2015 · 144 citations · Full text

Medicine, Neurology, Neuroscience +17

Immunotherapy with Aducanumab Restores Calcium Homeostasis in Tg2576 Mice

Ksenia V. Kastanenka, Thierry Bussière, Naomi Shakerdge et al. · Journal of Neuroscience · 2016 · 110 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Optogenetic Restoration of Disrupted Slow Oscillations Halts Amyloid Deposition and Restores Calcium Homeostasis in an Animal Model of Alzheimer’s Disease

Ksenia V. Kastanenka, Steven S. Hou, Naomi Shakerdge et al. · PLoS ONE · 2017 · 110 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Frequency-dependent exacerbation of Alzheimer’s disease neuropathophysiology

Ksenia V. Kastanenka, María Calvo-Rodríguez, Steven S. Hou et al. · Scientific Reports · 2019 · 49 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17